SACK1H and gallbladder carcinoma: Nuclear FAM83H positivity predicted a 2.823-fold [95% confidence interval (95% CI); 1.716–4.646] greater risk of death and a 2.685-fold (95% CI; 1.640–4.395) greater risk of relapse or death of gallbladder carcinoma patients.